Skip to main content
Caplight Logo









Animol Discovery

Animol Discovery

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://www.animol-discovery.com/

Last Round

Series C

Feb 3, 2025

Est. Valuation

$99.5M

Total Funding Raised

$44.5M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Animol Discovery is a biotechnology company that develops animal drug discovery technology to discover small-molecule active pharmaceutical ingredients.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Application

Keywords

animal healthdrug discoverysmall-molecule discoveryAI drug discoveryveterinary medicineanimal health biotechdrug discovery platformveterinary pharmaceuticalsDNA-encoded librariespet pharmaanimal pharmahigh throughput screeningcomputational chemistrycompanion animal healthlivestock healthDEL screening

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Animol Discovery Comparables

Compare Animol Discovery with similar companies based on industry and business-model similarity.

Animol Discovery comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ASTRA Therapeutics
83%
Vetigenics Inc.
78%
Peptidus Biotech
74%

Animol Discovery Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CFeb 3, 2025
Series BJul 28, 2022

Key People

Founding team and executive leadership

Anna Rath

Founder, CEO and Board Member

Founding Team

Douglas Hutchens

Chief Scientific Officer, Animol Discovery Advisory Board Member

Executive Team

Animol Discovery Investors

Notable investors and investment history

Animol Discovery investors
InvestorRounds
Anterra CapitalSeries B, Accelerator
Novalis LifeSciencesSeries C, Series B
Finistere VenturesSeries B, Series C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors increased 61% MoM, reaching 2.7K.

  • Jun 21, 2026

    Monthly visitors increased 41% MoM.

Animol Discovery Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Animol Discovery Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Animol Discovery's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range15
Year Founded2019
Last FundingFeb 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?